483
Inhibrx Biosciences Inc.Inhibrx Biosciences Inc. – FDA 483, Jul 2, 2026
Record Details
An FDA inspection of Inhibrx Biosciences Inc. in La Jolla, CA, identified multiple deficiencies in their role as a clinical trial sponsor. Observations included failures in proper study monitoring, ensuring accurate data, timely reporting of serious adverse events, and prompt communication of study results to investigator sites. These issues highlight significant lapses in oversight and adherence to protocol requirements during clinical investigations.
View Company Profile
ID · b72a5b67-10f7-4f17-b7a1-efe407156f53
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.